SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-072162
Filing Date
2022-11-14
Accepted
2022-11-14 16:02:47
Documents
56
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0922_gamidacell.htm   iXBRL 10-Q 1101058
2 CERTIFICATION f10q0922ex31-1_gamidacell.htm EX-31.1 9187
3 CERTIFICATION f10q0922ex31-2_gamidacell.htm EX-31.2 9144
4 CERTIFICATION f10q0922ex32-1_gamidacell.htm EX-32.1 3572
5 CERTIFICATION f10q0922ex32-2_gamidacell.htm EX-32.2 3536
  Complete submission text file 0001213900-22-072162.txt   3928429

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE gmda-20220930.xsd EX-101.SCH 44284
7 XBRL CALCULATION FILE gmda-20220930_cal.xml EX-101.CAL 25290
8 XBRL DEFINITION FILE gmda-20220930_def.xml EX-101.DEF 157141
9 XBRL LABEL FILE gmda-20220930_lab.xml EX-101.LAB 375976
10 XBRL PRESENTATION FILE gmda-20220930_pre.xml EX-101.PRE 171522
50 EXTRACTED XBRL INSTANCE DOCUMENT f10q0922_gamidacell_htm.xml XML 319204
Mailing Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484
Business Address 5 NAHUM HAFZADI STREET JERUSALEM L3 95484 97226595666
Gamida Cell Ltd. (Filer) CIK: 0001600847 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38716 | Film No.: 221384921
SIC: 2836 Biological Products, (No Diagnostic Substances)